Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report: July 12, 2011

 

 

MedQuist Holdings Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35069   98-0676666

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

I.D. No.)

9009 Carothers Parkway

Franklin, Tennessee

  37067
(Address of principal executive offices)   (Zip Code)

(866) 295-4600

Registrant’s telephone number, including area code

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 7.01 Regulation FD Disclosure.

Attached as Exhibit 99.1 is an investor presentation dated July 12, 2011.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.

  

Description

99.1    Investor Presentation dated July 12, 2011


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MedQuist Holdings Inc.
By  

/s/ Mark R. Sullivan

  Name:   Mark R. Sullivan
  Title:   General Counsel & Chief Compliance Officer

Date: July 12, 2011


Exhibit Index

 

Exhibit
No.

  

Description

99.1    Investor Presentation dated July 12, 2011